Philips announced that Kees Wesdorp, leader of Philips’ Precision Diagnosis businesses and member of the Executive Committee, has decided to leave Philips to pursue an opportunity in the private equity sector. Bert van Meurs, Chief Business Leader for the Image Guided Therapy businesses and member of the Executive Committee, will temporarily expand his current role to include leadership of the Precision Diagnosis businesses, effective as of January 1, 2023, until a permanent successor for Kees is appointed.
“I want to take this opportunity to thank Kees for his strong contribution to Philips. Since joining the company in 2017 he has made a significant impact, first leading the renewal of the innovation portfolio of our diagnostic imaging businesses, and, from 2020, leading our Precision Diagnosis strategy, with a focus on enabling clinicians to effectively guide patients through tailored care pathways”, said Roy Jakobs, CEO of Royal Philips. “In his expanded role, Bert will leverage his extensive leadership experience in the company to advance our ambitions across our Diagnosis & Treatment businesses.”
“I am proud of the achievements of the team during my tenure, during which time we’ve made major advances across our imaging systems businesses and diagnostic and pathway informatics solutions, always keeping the customer and the patient at the center of what we do,” said Kees Wesdorp, leader of Philips’ Precision Diagnosis businesses. “Philips will continue to play an important role in achieving better, more resilient, and sustainable healthcare for future generations.”
Bert van Meurs currently leads Philips’ Image Guided Therapy businesses, providing integrated solutions comprising interventional imaging systems, smart catheters, planning and navigation software, and services with the aim to improve minimally invasive treatments. He has been a member of the Philips Executive Committee since 2019.
Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.